Abstract
Annotation: The course of the severe form of the new coronavirus infection COVID-19 is often accompanied by the occurrence of a "cytokine storm". As a promising therapy for the treatment of this complication, immunobiological drugs are of increasing interest. The article discusses some drugs from this group, their using and the results of their therapy in severe COVID-19. Research methods – literature review, generalizing, analysis and conclusion.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
